These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38723553)

  • 1. Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays.
    Lind A; Freyhult E; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Larsson HE; Lundgren M; Carlsson A; Nilsson AL; Fex M; Törn C; Agardh D; Tsai CT; Lernmark Å;
    EBioMedicine; 2024 Jun; 104():105144. PubMed ID: 38723553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease.
    Lind A; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Agardh D; Larsson HE; Lundgren M; Tsai CT; Lernmark Å
    J Immunol Methods; 2022 Jul; 506():113265. PubMed ID: 35358496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type 1 diabetes.
    Ankelo M; Westerlund A; Blomberg K; Knip M; Ilonen J; Hinkkanen AE
    Clin Chem; 2007 Mar; 53(3):472-9. PubMed ID: 17259239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
    Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD
    Amoroso M; Achenbach P; Powell M; Coles R; Chlebowska M; Carr L; Furmaniak J; Scholz M; Bonifacio E; Ziegler AG; Rees Smith B
    Clin Chim Acta; 2016 Nov; 462():60-64. PubMed ID: 27570064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary Blood.
    Ziegler AG; Haupt F; Scholz M; Weininger K; Wittich S; Löbner S; Matzke C; Gezginci C; Riethausen S; Beyerlein A; Zillmer S; Amoroso M; Coles R; Powell M; Furmaniak J; Smith BR; Winkler C; Bonifacio E; Achenbach P
    Diabetes Technol Ther; 2016 Nov; 18(11):687-693. PubMed ID: 27552135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Itoh Y; Hanafusa T
    J Diabetes Investig; 2021 Apr; 12(4):510-515. PubMed ID: 32696593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.
    Törn C; Mueller PW; Schlosser M; Bonifacio E; Bingley PJ;
    Diabetologia; 2008 May; 51(5):846-52. PubMed ID: 18373080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
    Vermeulen I; Weets I; Asanghanwa M; Ruige J; Van Gaal L; Mathieu C; Keymeulen B; Lampasona V; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
    Diabetes Care; 2011 Aug; 34(8):1760-5. PubMed ID: 21715527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease.
    Zhao Z; Miao D; Michels A; Steck A; Dong F; Rewers M; Yu L
    J Immunol Methods; 2016 Mar; 430():28-32. PubMed ID: 26809048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the diagnostic efficiency of anti-ZnT8 autoantibodies for type 1 diabetes in pediatric patients.
    Fuentes-Cantero S; González-Rodríguez C; Rodríguez-Chacón C; Galvan-Toribio R; Hermosín-Escudero J; Pérez-Pérez A; León-Justel A
    Lab Med; 2024 May; 55(3):299-303. PubMed ID: 37658812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.